| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |